研究进展的结构和抗结肠直肠恶性瘤shikonin的特性
Jinghua Chen1,2, Jie Liu3, Weiwei Nie1
1Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China.
Journal of cancer research and therapeutics
|January 10, 2025
概括
石康宁作为结直肠癌 (CRC) 的抗癌剂显示出希望. 这篇评论探讨了Shikoninonin的情况.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 尽管治疗方面取得了进展,但CRC仍然是一个重大的健康问题.
- 石康宁是一种天然的纳夫托金,具有抗炎和抗瘤的特性.
研究的目的:
- 为了审查Shikonin在结肠直肠癌中的作用机制.
- 探索基于西康宁的疗法的潜在结构改进.
- 为针对结直肠癌的药物开发提供见解.
主要方法:
- 对现有研究的文献综述 希科宁和结直肠癌.
- 对西康宁的生物活动和机制的分析.
- 探索结构-活动关系和潜在的修改.
主要成果:
- 在临床前研究中,西康宁在对结直肠癌细胞具有显著的抗瘤作用.
- 确定了主要的分子标和受到Shikonin影响的途径.
- 对可能提高疗效和降低毒性结构修改的初步见解.
结论:
- 石康宁为结直肠癌治疗提供了一个有前途的治疗候选药物.
- 进一步研究Shikonin的机制和结构优化是有必要的.
- 基于西康宁的药物开发可能为结直肠癌提供新的药物选择.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.2K
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
935
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
